Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
0–16
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient weighs at least 40 kg.
Younger than 16 years old (no older than their 16th birthday).
Suspected acute bacterial sinusitis.
Able to swallow amoxicillin/clavulanate tablets.
You may not be if
Personal or family history of adverse reactions or hypersensitivity or allergy to any penicillin or cephalosporin antibiotics.
History of reaction to multiple allergens (if considered clinically relevant by the principal investigator).
Patient is participating in another clinical trial or has received or anticipates receiving an investigational drug, vaccine, or medical device prior to the first dose of study medication or during the conduct of the study.
History or presence of gastrointestinal, hepatic or renal disease or other conditions known to or that may interfere with the absorption, distribution, metabolism or excretion of study medication.
Treatment with probenecid or allopurinol within 7 days of study entry.
Female patients with a positive urine hCG (human chorionic gonadotropin) test at screening, or who are lactating (breast feeding) or are unwilling to be abstinent until completion of the follow-up visit.
History of diarrhea due to Clostridium difficile following treatment with antibiotics.
History of hypersensitivity or allergy to heparin or related preparations (if the clinical research unit uses heparin to maintain intravenous cannula patency).
